Growing European Multi-National Pharmaceutical Company Signs Agreement with eResearchTechnology for Cardiac Safety Monitoring an
03 December 2003 - 1:05AM
PR Newswire (US)
Growing European Multi-National Pharmaceutical Company Signs
Agreement with eResearchTechnology for Cardiac Safety Monitoring
and Information Distribution Services Award Totals Approximately
$1.4 Million for Thorough Phase I ECG Study to Be Completed Over 90
Days PHILADELPHIA, Dec. 2 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (eRT), , a leading provider of
centralized electrocardiographic (ECG) collection and
interpretation services, announced today that it has received an
agreement for approximately $1.4 million in cardiac safety
monitoring and services from a growing Europe-based multi-national
pharmaceutical organization for one of its drug candidates in later
phase clinical trials. The agreement covers an extensive Phase I
study for which eRT is providing comprehensive support including
the provision, training and ongoing assistance required for
effective use of digital 12-lead Holter equipment designed to
facilitate 24-hour digital recording of cardiac safety data that is
subsequently provided to eRT for analysis. eRT will perform digital
collection, measurement, interpretation, review, and distribution
of cardiac safety data through its EXPeRT workflow enabled data
handling technology, the first solution in production that was
designed explicitly to meet emerging international regulatory
guidance and technical standards. The study is targeted for
completion over a 90-day period beginning in the first quarter of
2004. "The developer of this compound learned recently that
completion of a Thorough Phase I ECG Study was important for
continuation of its clinical development program into Phase III and
through to submission," said Scott Grisanti, senior vice president
of business development and chief marketing officer at eRT. "We are
delighted that eRT is in a position to collaborate closely with
this organization by providing cardiac safety services for this
important initiative and to assist with a number of important
supporting services related to protocol development, selection of a
clinical pharmacology unit to conduct the trial, and general
planning and logistics." Based in Philadelphia, PA,
eResearchTechnology, Inc. (http://www.ert.com/) is a provider of
technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a
market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate
net revenues due to variability in size, scope and duration of
projects, and internal issues in the sponsoring client. As a
result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors
that could affect the company's financial results can be found in
the company's Reports on Forms 10-K and 10-Q filed with the
Securities and Exchange Commission. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Joan Sterlacci,
eResearchTechnology, +1-908-203-6473; or Matt Hayden, Hayden
Communications, +1-760-487-1137, for eResearchTechnology Web site:
http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles